SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020547
Filing Date
2021-04-26
Accepted
2021-04-26 16:30:27
Documents
14
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A pbyi-def14a_20210615.htm DEF 14A 2464800
2 GRAPHIC gtazv5hv5eby000008.jpg GRAPHIC 1059
3 GRAPHIC gtazv5hv5eby000002.jpg GRAPHIC 45411
4 GRAPHIC gtazv5hv5eby000003.jpg GRAPHIC 25014
5 GRAPHIC gtazv5hv5eby000005.jpg GRAPHIC 23371
6 GRAPHIC gtazv5hv5eby000013.jpg GRAPHIC 938
7 GRAPHIC gtazv5hv5eby000009.jpg GRAPHIC 1059
8 GRAPHIC gtazv5hv5eby000012.jpg GRAPHIC 1130
9 GRAPHIC gtazv5hv5eby000007.jpg GRAPHIC 11540
10 GRAPHIC gtazv5hv5eby000006.jpg GRAPHIC 45411
11 GRAPHIC gtazv5hv5eby000001.jpg GRAPHIC 25014
12 GRAPHIC gtazv5hv5eby000004.jpg GRAPHIC 45411
13 GRAPHIC gtazv5hv5eby000011.jpg GRAPHIC 1030
14 GRAPHIC gtazv5hv5eby000010.jpg GRAPHIC 21846
  Complete submission text file 0001564590-21-020547.txt   2809723
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 21854227
SIC: 2834 Pharmaceutical Preparations